Design and Structure-Based Study of New Potential FKBP12 Inhibitors

Biophysical Journal

Volumn 85, Issue 5, 2003, Pages 3194-3201

  Sun, Fei ^a,d   Li, Pengyun ^a   Ding, Yi ^a   Wang, Liwei ^a   Bartlam, Mark ^a   Shu, Cuilin ^b   Shen, Beifen ^b   Jiang, Hualiang ^c   Li, Song ^b   Rao, Zihe ^a,d  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; 4 (4 TOLUENESULFONYL) 1,4 THIAZANE 3 CARBOXYLIC ACID PHENYLALANINE BENZYL ESTER; 4 (4 TOLUENESULFONYL) 1,4 THIAZENE 3 CARBOXYLIC ACID LEUCINE ETHYL ESTER; BINDING PROTEIN; COMPOUND 107; COMPOUND 308; LIGAND; PROTEIN INHIBITOR; RAPAMYCIN; TACROLIMUS; TSUKUBAENOLIDE BINDING PROTEIN; TSUKUBAENOLIDE BINDING PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; COMPLEX FORMATION; COMPUTER; DRUG BINDING; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENERGY; FLUORESCENCE; NERVE REGENERATION; X RAY CRYSTALLOGRAPHY;

EID: 10744231509     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(03)74737-7     Document Type: Article

References (41)

1. Adalsteinsson, H., and T. C. Bruice. 2000. Generation and evaluation of putative neuroregenerative drugs. Part 2: screening virtual libraries of novel polyketides which possess the binding domain of rapamycin. Bioorg. Med. Chem. 8:625-635.
2. Becker, D. B., J. N. Jensen, T. M. Myckatyn, V. B. Doolabh, D. A. Hunter, and S. E. Mackinnon. 2000. Effects of FKBP-12 ligands following tibial nerve injury in rats. J. Reconstr. Microsurg. 16:613-620.
3. Becker, J. W., J. Rotonda, J. G. Cryan, M. Martin, W. H. Parsons, P. J. Sinclair, G. Wiederrecht, and F. Wong. 1999. 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. J. Med. Chem. 42:2798-2804.
4. Becker, J. W., J. Rotonda, B. M. McKeever, H. K. Chan, A. I. Marcy, G. Wiederrecht, J. D. Hermes, and J. P. Springer. 1993. FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. J. Biol. Chem. 268:11335-11339.
5. Brünger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D. Biol. Crystallogr. 54:905-921.
6. Choi, J., J. Chen, S. L. Schreiber, and J. Clardy. 1996. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science. 273:239-242.
7. Christner, C., R. Wyrwa, S. Marsch, G. Kullertz, R. Thiericke, S. Grabley, D. Schumann, and G. Fischer. 1999. Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. J. Med. Chem. 42:3615-3622.
8. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:695-697.
9. Dawson, T. M., J. P. Steiner, W. E. Lyons, M. Fotuhi, M. Blue, and S. H. Snyder. 1994. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. Neuroscience. 62:569-580.
10. Denesyuk, A. I., K. A. Denessiouk, V. P. Zav'yalov, J. Lundell, and T. Korpela. 1998. Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin. Comput. Chem. 22:339-344.
11. Gold, B. G. 2000. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin. Invest. Drugs. 9:2331-2342.
12. Gold, B. G., M. Zeleny-Pooley, M. S. Wang, P. Chaturvedi, and D. M. Armistead. 1997. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:269-278.
13. Graziani, F., L. Aldegheri, and G. C. Terstappen. 1999. High throughput scintillation proximity assay for the identification of FKBP-12 ligands. J. Biomol. Screen. 4:3-7.
14. Griffith, J. P., J. L. Kim, E. E. Kim, M. D. Sintchak, J. A. Thomson, M. J. Fitzgibbon, M. A. Fleming, P. R. Caron, K. Hsiao, and M. A. Navia. 1995. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 82:507-522.
15. Guo, X., V. L. Dawson, and T. M. Dawson. 2001. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci. 13:1683-1693.
16. Hauske, J. R., P. Dorff, S. Julin, J. DiBrino, R. Spencer, and R. Williams. 1992. Design and synthesis of novel FKBP inhibitors. J. Med. Chem. 35:4284-4296.
17. Herdegan, T., G. Fischer, and B. G. Bold. 2000. Immunophilin ligands as a novel treatment of neurological disorders. Trends Pharmacol. Sci. 21:3-5.
18. Huse, M., Y. G. Chen, J. Massague, and J. Kuriyan. 1999. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 96:425-436.
19. Kissinger, C. R., H. E. Parge, D. R. Knighton, C. T. Lewis, L. A. Pelletier, A. Tempczyk, V. J. Kalish, K. D. Tucker, R. E. Showalter, E. W. Moomaw, L. N. Gastinel, N. Habuka, X. Chen, F. Maldonado, J. E. Barker, R. Bacquet, and J. E. Villafranca. 1995. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 378:641-644.
20. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
21. Li, P., L. Wang, B. Wu, C. Shu, A. Nie, B. Shen, S. Li, and Z. Rao. 2003. Crystallization and preliminary x-ray diffraction analysis of FKBP12 complexed with a new neurotrophic ligand. Progr. Natur. Sci. 13:765-767.
22. Li, P., L. Wang, Y. Ding, B. Wu, C. Shu, A. Nie, S. Li, B. Shen, and Z. Rao. 2002. Crystallization and preliminary x-ray diffraction analysis of FKBP12 complexed with a novel neurotrophic ligand. Prot. Peptide Lett. 9:459-463.
23. Liu, J., J. D. Farmer, Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:807-815.
24. Lyons, W. E., E. B. George, T. M. Dawson, J. P. Steiner, and S. H. Snyder. 1994. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. USA. 91:3191-3195.
25. Morris, G. M., D. S. Goodsell, R. S. Halliday, R. Huey, R. W. E. Hart, R. K. Belew, and A. J. Olson. 1998. Automated docking using Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19:1639-1662.
26. Morris, G. M., D. S. Goodsell, R. Huey, W. E. Hart, S. Halliday, R. Belew, and A. J. Olson. 1999. AUTODOCK, V. 3.0.3. The Scripps Research Institute, Molecular Graphics Laboratory, Department of Molecular Biology.
27. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:281-296.
28. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffraction data collected in oscillation mode. C. W. Carter, Jr., and R. M. Sweet, editors. Academic Press. 307-326.
29. Park, S. T., R. A. Aldape, O. Futer, M. T. DeCenzo, and D. J. Livingston. 1992. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. J. Biol. Chem. 267:3316-3324.
30. Pei, W-H, Y.-H. He, X. Chen, S. Li, and B.-F. Shen. 2000. Solube expression and activity research of human FKBP12. J. Cell. Mol. Immunol. (in Chinese). 16:204-206.
31. Sabatini, D. M., M. M. Lai, and S. H. Snyder. 1997. Neural roles of immunophilins and their ligands. Mol. Neurobiol. 15:223-239.
32. Sauer, H., J. M. Francis, H. Jiang, G. S. Hamilton, and J. P. Steiner. 1999. Systemic treatment with GPI 1046 improves spatial memory and reverses cholinergic neuron atrophy in the medial septal nucleus of aged mice. Brain Res. 842:109-118.
33. Schiene, C., and G. Fischer. 2000. Enzymes that catalyse the restructuring of proteins. Curr. Opin. Struct. Biol. 10:40-45.
34. Sich, C., S. Improta, D. J. Cowley, C. Guenet, J. P. Merly, M. Teufel, and V. Saudek. 2000. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics. Eur. J. Biochem. 267:5342-5355.
35. Snyder, S. H., D. M. Sabatini, M. M. Lai, J. P. Steiner, G. S. Hamilton, and P. D. Suzdak. 1998. Neural actions of immunophilin ligands. Trends Pharmacol. Sci. 19:21-26.
36. Steiner, J. P., T. M. Dawson, M. Fotuhi, C. E. Glatt, A. M. Snowman, N. Cohen, and S. H. Snyder. 1992. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:584-587.
37. Steiner, J. P., M. A. Connolly, H. L. Valentine, G. S. Hamilton, T. M. Dawson, L. Hester, and S. H. Snyder. 1997a. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 4:412-428.
38. Steiner, J. P., G. S. Hamilton, D. T. Ross, H. L. Valentine, H. Guo, M. A. Connolly, S. Liang, C. Ramsey, J. H. Li, W. Huang, et al. 1997b. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:2019-2024.
39. Wilson, K. P., M. M. Yamashita, M. D. Sintchak, S. H. Rotstein, M. A. Murcko, J. Boger, J. A. Thomson, M. J. Fitzgibbon, J. R. Black, and M. A. Navia. 1995. Comparative x-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. Acta Crystallogr. D. 51:511-521.
40. Winter, C., J. Schenkel, E. Burger, C. Eickmeier, M. Zimmermann, and T. Herdegen. 2000. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. Neuroscience. 95:753-762.
41. Zhang, C., J. P. Steiner, G. S. Hamilton, T. P. Hicks, and M. O. Poulter. 2001. Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment. J. Neurosci. 21:RC156.